DRY NEEDLING VS. CUPPING THERAPY IN MPS
2026년 6월 30일 업데이트: Fatma Nur BULDUK, Turkish League Against Rheumatism
COMPARISON OF THE EFFECTIVENESS OF DRY NEEDLING AND CUPPING THERAPY IN PATIENTS WITH MYOFASCIAL PAIN SYNDROME: A RANDOMIZED TRIAL
This study aimed to compare the effectiveness of dry needling and cupping therapy in patients diagnosed with myofascial pain syndrome involving the trapezius, supraspinatus, infraspinatus, and levator scapulae muscles.
Treatment efficacy was evaluated using the visual analog scale (VAS), the number of trigger points, the Likert satisfaction scale, and the multidimensional quality of life scale.
연구 개요
상태
상태
완전한
정황
정황
개입 / 치료
개입 / 치료
상세 설명
This study evaluated the effectiveness of dry needling (DN) and cupping therapy in 92 patients with chronic myofascial pain syndrome. Participants were randomly divided into two groups: one receiving a 10-session cupping regimen and the other undergoing a three-session dry needling protocol, with both groups performing home-based exercises.
Results showed that both treatments significantly reduced pain and improved patient outcomes over three months. When compared directly, cupping therapy was more effective at reducing trigger points and improving overall quality of life. Conversely, dry needling resulted in higher levels of patient satisfaction. In conclusion, both methods are valuable tools for managing myofascial pain, and the choice of treatment may depend on whether the clinical priority is physical symptom relief or patient preference. Further research is recommended to better define the specific long-term applications of these therapies.
연구 유형
연구 유형
중재적
등록 (실제)
등록
92
단계
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 장소
-
-
-
Erzurum, 터키 (Türkiye), 25240
- Ataturk University
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
자격 기준
공부할 수 있는 나이
- 성인
건강한 자원 봉사자를 받아들입니다
아니
설명
Inclusion Criteria:
- Back pain lasting more than three months
- At least one palpable myofascial TN in the trapezius, supraspinatus, infraspinatus, and/or levator scapulae muscles
- Written informed consent
Exclusion Criteria:
- Prior dry needling treatment
- Prior cupping therapy
- Severe cognitive dysfunction
- Spinal fracture
- Infection
- Malignancy
- Ankylosing spondylitis
- Central nervous system injury
- Psychiatric disorder
- Diseases causing tissue degeneration
- Conditions associated with spasticity or cerebrovascular disease
- Cervical radiculopathy due to structural abnormalities
- Muscle or tendon injuries of the shoulder or neck
- Fibromyalgia or other conditions presenting with symptoms similar to myofascial pain syndrome
- Use of anticoagulant or antiplatelet therapy
- Thrombocytopenia or hemorrhagic disorders
- A history of surgery or blood donation within the previous three months
- Pregnancy
- Breastfeeding
- Presence of renal, hepatic, or severe cardiovascular disease
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
2
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
활성 비교기: Cupping therapy arm
Dry cupping was conducted 3 times per week for 9 sessions, followed by one session of wet cupping at the tenth session.
|
In the tenth session, wet cupping was performed directly over the patients' TNs.
In addition to the TNs, wet cupping was also applied at the Dazhui DU-14 point in all patients.
Before initiating the procedure, the treatment area was disinfected with alcohol.
Sterile single-use cups numbered 5 and 6 were applied to the treatment area.
After 3 to 5 minutes, the cups were removed one at a time.
After the area was cleaned, a No. 15 scalpel blade was used to make shallow vertical cuts at the cupping site.
Afterward, the cups were returned to the same places.
The procedure was performed three times without making any new cuts.
The blood was drained, and the cups were put back on.
The entire procedure lasted approximately 20 min.
The cups were removed at the end of the procedure, and the area that had been treated was cleaned and covered properly.
|
|
활성 비교기: Dry needling arm
Participants in this arm received three sessions of dry needling, administered once per week.
|
Needling was performed while the TNs in the levator scapulae, supraspinatus, and upper part of the trapezius muscles were sitting.
Patients were placed in the prone position for the middle and lower parts of the trapezius and infraspinatus muscles.
To increase the accuracy of localization and minimize the risk of injury to nearby structures, needling was performed under ultrasound guidance.
We used the Esaote MyLab 60 ultrasound machine that we have in our clinic for this.
Standard single-use sterile acupuncture needles (0.25 mm × 25 mm) were used.
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Visual analog scale
기간: From enrollment to the end of the first month
|
The VAS score was used to measure pain intensity in each patient.
Patients were told to rate their pain on a 10-cm horizontal line for the VAS test.
A score of 0 indicated no pain, a score of 5 indicated moderate pain, and a score of 10 indicated the worst pain.
|
From enrollment to the end of the first month
|
|
Trigger points count
기간: From enrollment to the end of the first month
|
Trigger points were identified in the trapezius, levator scapulae, supraspinatus, and infraspinatus muscles by the presence of a hypersensitive spot within a palpable taut band, accompanied by a visible or palpable LTR and/or reproduction of referred pain upon palpation of the sensitive point.
|
From enrollment to the end of the first month
|
|
Multidimensional quality of life score
기간: From enrollment to the end of the first month
|
The multidimensional quality of life scale includes a total of 35 items and assesses nine subdomains, each with four items.
The overall score is obtained by summing the responses to all the items.
Each item is given a score from 1 to 7, with a total score of 35 to 245.
Higher scores indicate better functional status.
|
From enrollment to the end of the first month
|
|
Likert satisfaction scale
기간: From enrollment to the end of the first month
|
Patient satisfaction was assessed using a Likert scale, where participants were asked to rate their experience by selecting one of the following options: none, mild, moderately good, good, or very good.
|
From enrollment to the end of the first month
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Visual analog scale
기간: From enrollment to the end of the third month
|
The VAS score was used to measure pain intensity in each patient.
Patients were told to rate their pain on a 10-cm horizontal line for the VAS test.
A score of 0 indicated no pain, a score of 5 indicated moderate pain, and a score of 10 indicated the worst pain.
|
From enrollment to the end of the third month
|
|
Trigger points count
기간: From enrollment to the end of the third month
|
Trigger points were identified in the trapezius, levator scapulae, supraspinatus, and infraspinatus muscles by the presence of a hypersensitive spot within a palpable taut band, accompanied by a visible or palpable LTR and/or reproduction of referred pain upon palpation of the sensitive point.
|
From enrollment to the end of the third month
|
|
Multidimensional quality of life score
기간: From enrollment to the end of the third month
|
The multidimensional quality of life scale includes a total of 35 items and assesses nine subdomains, each with four items.
The overall score is obtained by summing the responses to all the items.
Each item is given a score from 1 to 7, with a total score of 35 to 245.
Higher scores indicate better functional status.
|
From enrollment to the end of the third month
|
|
Likert satisfaction scale
기간: From enrollment to the end of the third month
|
Patient satisfaction was assessed using a Likert scale, where participants were asked to rate their experience by selecting one of the following options: none, mild, moderately good, good, or very good.
|
From enrollment to the end of the third month
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
협력자
협력자
수사관
수사관
- 연구 책임자: Fatih Baygutalp, Medical doctor, Department of Physical Medicine and Rehabilitation, Ataturk University Faculty of Medicine
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
연구 시작
2022년 3월 15일
기본 완료 (실제)
기본 완료
2024년 6월 30일
연구 완료 (실제)
연구 완료
2025년 8월 29일
연구 등록 날짜
최초 제출
최초 제출
2026년 6월 30일
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
2026년 6월 30일
처음 게시됨 (실제)
처음 게시됨
2026년 7월 7일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
2026년 7월 7일
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
2026년 6월 30일
마지막으로 확인됨
마지막으로 확인됨
2026년 6월 1일
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- B.30.2.ATA.0.01.00/286
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
예
IPD 계획 설명
All the patients' demographic characteristics, including age, sex, educational level, occupation, height and weight
IPD 공유 기간
Beginning 1 year after publication with no end date
IPD 공유 액세스 기준
Access to individual participant data (IPD) and supporting documentation is provided to the principal investigators and the designated research team.
Additionally, access may be granted to journal editors and peer reviewers upon request for the purposes of data verification and manuscript evaluation.
All shared information consists exclusively of de-identified, anonymized raw data to ensure participant privacy.
Access is managed on a request-only basis, ensuring that data is shared securely and in accordance with ethical standards and institutional guidelines.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- ICF
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
아니
미국 FDA 규제 기기 제품 연구
아니
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
근시 통증 증후군 (MP)에 대한 임상 시험
Cupping therapy에 대한 임상 시험
-
NCT07147933모병뇌성마비(CP) | 웅크린 걸음걸이 | 근육 약화 | 인내심 있는 | Diaplegia | 전방 골반 경사